News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Algorae Pharmaceuticals.
RELATED STOCKHEAD STORIES
News
ASX Small Caps Lunch Wrap: CPI data put a rocket up the ASX, but REX is circling the drain
Health & Biotech
ASX Health Stocks: Here’s an update on Algorae’s AI-powered drugs discovery platform
Health & Biotech
ASX Health Stocks: US bound Telix plans dual listing on the NASDAQ
Health & Biotech
ASX Health Stocks: Chimeric jumps 35pc as cell therapy drug shows pre-clinical efficacy
News
In Case You Missed It: Lithium land secured in Canada’s Electric Avenue takes PAT higher
Health & Biotech
ASX Health Stocks: Chimeric surges 70pc after FDA approval, takes its CAR T cell drug to the clinic
News
ASX Small Caps and IPO Weekly Wrap: Things went better than expected in a week all about lithium and uranium
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: Catch up footy leaves benchmark nibbling at parity for second straight session
News
ASX Small Caps Lunch Wrap: Who’s elevated being drunk and lazy to an art form this week?
News
In Case You Missed It: Construction materials player beats resources for top spot
Health & Biotech
Algorae, UNSW work on ‘revolutionary’ AI platform to accelerate drug discovery and development
News
Market Highlights: Wall Street’s late selloff, home prices rebound, and 5 ASX small caps to watch today
News
ASX Health Stocks: Living Cells Tech files a patent for cannabis-based dementia drug
Health & Biotech
ASX Health Stocks: AVITA’s spray-on skin cells device RECELL pockets US FDA approval
News
CLOSING BELL: Shipments increase after China lifts the ban it never put on Aussie coal
Health & Biotech
